Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adicon HoldingsADCNF 75 EPS without NRI is $0.01 as of Dec. 2025. GuruFocus rates ADCNF with a GF Score™ of 75/100 and a GF Value™ of $1.19. The stock has 6 warning signs investors should review. Among 159 Medical Diagnostics & Research companies, Adicon Holdings ranks worse than 93.71% on this metric.
Adicon Holdings's earnings per share without non-recurring items for the
six
months ended in Dec. 2025 was $-0.00.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01.
During the past 12 months, Adicon Holdings's average earnings per share (NRI) Growth Rate was -58.70% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -56.90% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -29.60% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Adicon Holdings's EPS without NRI or its related term are showing as below:
ADCNF'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -56.9 Med: -26.9 Max: -6.4
Current: -56.9
During the past 6 years, Adicon Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -6.40% per year. The lowest was -56.90% per year. And the median was -26.90% per year.
ADCNF's 3-Year EPS without NRI Growth Rate is ranked worse than 93.71% of 159
companies
in the Medical Diagnostics & Research industry
Industry Median: 10.8
vs ADCNF: -56.90
Adicon Holdings's EPS (Diluted) for the
six
months ended in Dec. 2025 was $-0.00.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01.
Adicon Holdings's EPS (Basic) for the
six
months ended in Dec. 2025 was $-0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01.
Adicon Holdings (OTCPK:ADCNF) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Adicon Holdings EPS without NRI Related Terms
Adicon Holdings EPS without NRI Historical Data
* Premium members only.
The historical data trend for Adicon Holdings's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADCNF vs TMO, DHR, IDXX: EPS without NRI Comparison
For the Diagnostics & Research subindustry, Adicon Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adicon Holdings PE Ratio without NRI vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Adicon Holdings's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adicon Holdings (ADCNF) has a EPS without NRI of $0.01 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Adicon Holdings and its competitors. According to the industry distribution chart, Adicon Holdings ranks #149 out of 159 companies in the Medical Diagnostics & Research industry, placing it in the top 93.7%.
Is Adicon Holdings' EPS without NRI too high?
Adicon Holdings' current EPS without NRI is $0.01. The Medical Diagnostics & Research industry median EPS without NRI is 10.80. Adicon Holdings' value of $0.01 is 99.9% below this industry median. Based on the distribution chart, Adicon Holdings ranks #149 out of 159 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Adicon Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Adicon Holdings' EPS without NRI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Adicon Holdings ranks #149 out of 159 companies for EPS without NRI. This places Adicon Holdings in the lower half of its industry. The industry median EPS without NRI is 10.80. Adicon Holdings' value of $0.01 is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.80, based on 159 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adicon Holdings's current EPS without NRI of $0.01 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Adicon Holdings and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adicon Holdings's current EPS without NRI is $0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicon Holdings stock overvalued right now?
Adicon Holdings (ADCNF) has a current EPS without NRI of $0.01. The stock's GF Value™ is $1.19, compared to a current price of $0.65 — trading 45.4% below its estimated fair value. The current EPS without NRI is $0.01 and 99.9% below the Medical Diagnostics & Research industry median of 10.80. Adicon Holdings' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Adicon Holdings (ADCNF), the current EPS without NRI is $0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adicon Holdings (ADCNF) Overvalued in 2026?
Based on GuruFocus' analysis, Adicon Holdings stock appears to be undervalued.
The current stock price of $0.65 is trading 45.4% below its estimated GF Value™ of $1.19.
Key valuation signals for ADCNF:
EPS without NRI: $0.01
GF Value™: $1.19 vs. price of $0.65 (45.4% below fair value)
Industry Position: 99.9% below the Medical Diagnostics & Research median (#149 of 159)
No single metric tells the full story. See the ADCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adicon Holdings Ltd is a ICL service provider in China. It offers comprehensive testing services to hospitals and health check centers through an integrated network of self-operated laboratories across China. Its testing services platform includes clinical laboratories, pathology laboratories, reproductive genetics laboratories, gene laboratories, and mass spectrometry laboratories, consisting of over 4,000 medical diagnostic tests, the introduction of over 300 new high-end diagnostic tests.
75GF Score
Get the complete analysis for ADCNF
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADCNF has been successfully added to your 
